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The human placental receptor (cQMR) for a*-macroglobulin-proteinase complexes contains 3 polypeptides of approx. 500 kDa, 85 kDa, and 40 
kDa. N-terminal sequence analysis of the 500 kDa and 85 kDa polypeptides, analysis of a random selection of peptides covering 536 residues 
from these polypeptides, and analysis of a 1772 bp cDNA encoding part of the 500 kDa polypeptide provide evidence that the 500 kDa and 85 
kDa chains are the a- and p-subunits, respectively, of a recently cloned hepatic membrane protein, termed the low density lipoprotein receptor 
related protein (LRP) (Herz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H. and Stanley, K.K. (1988) EMBO J. 7, 41194127; Herz, 
J., Kowal, R.C., Goldstein, J.L. and Brown, MS. (1990) EMBO J. 9, 176991776). N-terminal sequence analysis of the 40 kDa polypeptide shows 
that it is of distinct genetic origin. It is suggested that LRP is the functional receptor for Q-macroglobulin-proteinase complexes (a,MR) and in 
addition may have as yet unsettled functions in lipoprotein metabolism. 
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1. INTRODUCTION 
Herz et al. [l] recently cloned cDNA encoding a large 
novel human glycoprotein with structural features sug- 
gesting a function as a recycling lipoprotein receptor. 
The protein, designated LRP, is expressed in 
hepatocytes and several other cell types [l]. The 600 
kDa LRP precursor is processed into a 85 kDa C- 
terminal membrane spanning P-subunit (601 residues) 
and a 5 15 kDa N-terminal a-subunit (3920 residues) re- 
maining tightly noncovalently bound to the ex- 
tracellular part of the P-subunit [2]. 
The tetrameric human auz-macroglobulin (CXZM) 
reacts with and inhibits a wide variety of proteinases, 
and, as a result of the formation of stable complexes, 
the conformation of the CY~M subunits changes so that 
previously concealed receptor binding domains become 
exposed. CYZM and other aMs participate in controlling 
the activity of proteinases by functioning as ‘clearing 
vehicles’ for proteinases (reviewed in [3]). 
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The partial protein sequences and nucleotide sequences have been 
deposited at EMBL/GenBank, accession number X55077 
(r2MR, the receptor for azM complexed with pro- 
teinase, has been characterized in several cell types, 
notably hepatocytes [4-61, and receptor-mediated en- 
docytosis into these cells largely accounts for the rapid 
removal of complexes from the circulation [7-91. CYZMR 
was recently isolated by affinity chromatography from 
rat liver [lo] and human placenta membranes [11,121. 
The preparations contained three components 
[10,12,13]: a species judged to migrate as a 420-440 
kDa polypeptide in SDS-PAGE, but possibly larger [ 1 l] 
(this component will be referred to below as the 500 
kDa chain of (Y~MR); a set of species migrating as a dif- 
fuse band corresponding to 70-85 kDa [l l] (the major 
component of this band will be referred to as the 85 kDa 
chain of a2MR); and a species of 40 kDa. High affinity 
binding of Ca2 + to the 500 kDa chain results in a con- 
formational change necessary for binding a2M- 
proteinase [ 131. Electron microscopic gold im- 
munocytochemistry using monoclonal antibodies 
against the 500 kDa chain revealed that the majority of 
the receptors in fibroblasts and monocytes are in in- 
tracellular vesicles and tubular structures [ 141. Within 
experimental error the amino acid composition of the 
500 kDa a2MR chain [13] is identical to that calculated 
from the sequence of the LRP a-subunit [1,2]. 
Here we provide evidence from partial sequence 
analysis (protein and DNA level) that the LRP (Y- 
subunit is the 500 kDa chain of a2MR, and that the 
LRP B-subunit is the 85 kDa chain of CY~MR. The 40 
kDa polypeptide is not related to LRP. The role of 
CYZMR for clearance of cyzM-proteinase complexes 
seems beyond doubt, whereas a possible role for bind- 
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ing and clearance of lipoproteins is under debate 
[ 15- 191. We therefore suggest hat the originahy cloned 
protein functions as the receptor for AIM-proteinase 
complexes and in addition may have as yet unsettled 
functions in lipoprotein metabolism. 
2. MATERIALS AND METHODS 
2. I. Proteins 
Human placental oaMR was isolated by affinity chromatography 
using immobibzed methylamine-treated ozM as described earlier [ 1 l]_ 
2.2. Peptide separation and protein sequence analysis 
Peptides were separated by reverse phase HPLC on columns of 
Nucleosil Cl& 5 pm (4.250 mm) and Aquapore (2.1.200 mm) using 
0.1% trifluoroacetic acid as the aqueous olvent, and gradient elution 
with ethanol or acetonitrile. Most peptide pools were 
rechromatographed using shallow gradients of organic solvent. Large 
CNBr fragments (>8 kDa) were separated by SDS-PAGE using 
standard 15% or 20% Tris/glycine gels and electroblotted onto 
PVDF membranes [20] (ProBlott, Applied Biosystems). Automated 
Edman degradation of IO-50 pmol samples was performed using an 
Applied Biosystems model 477A sequencer equipped with a model 
120A on-line HPLC operated according to the manufacturer’s in- 
structions. 
2.3. Materials for cDNA cloning 
Restriction endonucleases and DNA modifying enzymes were pur- 
chased from Boehringer Mannheim. A Sequenase kit was from 
United States Biochemicals. mRNA purification kits were from Phar- 
macia, and cDNA synthesis and cloning kits were from Amersham. y- 
]“P]ATP was from ICN. 
2.4. Construction of cDNA library 
Total RNA was purified from freshly obtained placentas by the 
guanidine thiocyanate method [21], and poly(A)+ mRNA was 
selected by obgo-dT-Sepharose chromatography. The poly(A) i 
selected mRNA was subjected to ultracentrifugation i a sucrose gra- 
dient, and RNA larger than approx. 4800 nucleotides was used in con- 
structing a randomly primed cDNA library 122,231 according to the 
manufacturer’s instructions. 
2.5. cDNA cloning and sequence analysis 
Degenerate oligo-deoxynucleotide probes corresponding to partial 
peptide sequences (6-8 residues) were synthesized on an Applied 
Biosystems model 381A DNA synthesizer and used for screening the 
cDNA library. Screening, colony purification, cDNA sequencing of 
restriction fragments and compilation of sequence data were perform- 
ed as reported earlier [24]. From the probe based on the sequence Gln- 
Cys-Asp-Tyr-Asp-Asn-Asp-Cys several hybridizing colonies were 
identified, and one having an insert of approx. 1700 bp was further 
characterized. The cDNA sequence and the derived protein sequence 
were compared to sequences contained in the GenBank (release 23) 
and MIPSX (release 16) databases [25]. 
3. EXPERIMENTAL 
For structural studies 800-1000 pmol ozMR was freezedried, 
redissolved in 50% formic acid and subjected to gel chromatography 
on a 24-ml column of Superose 12 eluted with the same solvent. The 
500 kDa chain eluted as a sharp peak followed by a broad peak con- 
taining the 85 kDa and 40 kDa species [13]. The material in each peak 
was pooled, freezedried, reduced with dithioerythritol, and alkylated 
with [?]iodoacetic acid. The Scarboxymethylated preparations 
were recovered by passage through a &ml Sephadex G-25F column 
eiuted with 50% formic acid. Four digests were investigated. (i) 
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Following treatment of the 500 kDa chain with CNBr the material was 
fractionated by Superose 12 gel chromatography using 50% formic 
acid as solvent. The large fragments were collected in two pools, 
separately digested with trypsin, and the peptides separated by 
HPLC. The smafl CNBr fragments were directly fractionated by 
HPLC. (ii) Peptides from a tryptic digest of the 500 kDa chain were 
initially fractionated on a Mono Q column (HR5/5) using gradient 
elution with ammoniumbicarbonate at pH 8.5 (10-500 mM). The ef- 
fluent was collected in 25 pools, and the peptides in 14 of these were 
further separated by HPLC. (iii) A second CNBr digest of the 500 
kDa chain was fractionated on Superose 12 as described above, but 
the effluent was collected in 8 pools. Two pools containing the ma- 
jority of the large CNBr fragments were separated by SDS-PAGE and 
electroblotted. Three pools containing the small CNBr fragments 
were separated by HPLC. (iv) The pools from the initial separations 
containing the 70-85 kDa and 40 kDa species were either treated with 
CNBr and separated by SDS-PAGE or directly separated by SDS- 
PAGE followed by ele~roblotting. In the latter case the 85 kDa and 
the 70-75 kDa species were analyzed separately. 
4. RESULTS 
The SDS-PAGE pattern of the a2MR preparation is 
shown in Fig. 1. The size of the largest chain of CYZMR 
is compatible with that of a 500 kDa species. The size of 
heavy chain of laminin has been estimated at 400 kDa 
or 440 kDa (cf. [lo]), and 400 kDa was previously 
chosen as the reference value [ 10-131. Thus, 420 kDa 
1121 or 440 kDa [ 10,l 1,131 previously published for the 
size of the large chain of CYZMR are likely to be 
underestimates. As judged from the staining intensities 
of the bands the 40 kDa peptide could be present in a 
1:l stoichiometry with the 500 kDa and the 85 kDa 
chains. Since ligand [lo-121 and Ca2 + [ 131 binding ac- 
tivities are found in the 500 kDa chain this was initially 
selected for sequence studies. 
kDa aSiR 
ry 500 kDa 
85 kDa 
40 kDa 
Fig. 1. SDS-PAGE of olzMR purified by affinity chromatography. 
The gel contained 4-16% polyacrylamide and was run at reducing 
conditions. The size (kDa) and position for the following protein 
standards: lactate dehydrogenase (36), catalase (60), phosphorylase b
(93), oaM subunit (ISO), th~oglobulin (330), and Iaminin heavy chain 
(440) are indicated. 
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Table I 
Stretches of amino acid seauence from a?MR 
Partial sequence Position in proLRP 
seauence 
AIDAPKTC? l-8 
GKVFFTDYGQIPKVERCDb 316-333 
DGQNRTKLVDSKIV= 335-348 
IPIENLMb 534-540 
YWTDWEEDPKDSRRGRLERAWb 644-664 
SERPPIFEIRd 165-114 
YDAQQQQVGTNKC 716-781 
CISKAWVCDGDND’ 1099-1111 
ELGPDNHTCQIQ 1194-1205 
EVLRGHEFLSHPF’ 1451-1463 
EIRGVDLDAPYYNYIISF’ 1573-1590 
VY WSDVRd 1610-1616 
NLFWTSYDTNKKd 1652-1663 
GDKLWWADQVSEKb 1777-1789 
GLSTISRAKRDQTWREDV’ 1923-1940 
AITVHPEKGYLFWTEWGQYPRd 1993-2013 
FSVSVFEDFIYWSD’ 2080-2093 
KNVIALAFDYRAC 2215-2226 
IFFSDIHFGNIQQINDDGSe 2236-2254 
FWTNWNEQHPSIb 2328-2339 
RAALSGANVLTLIE’ 2341-2354 
GIIAVANDTN’ 2447-2456 
GVLFQPCERTSLCYAPSW’ 2635-2652 
TSLCYAPSWVCDGANDCGDYe 2644-2663 
CIPMSWTCDKE’ 2689-2699 
CISKQWLCDGSDDCGDGSDEAAe 2721-2748 
CQNRQCIPKHFVCDC 2806-2819 
CLSSRQWECDGEND’ 2851-2864 
IYWTDVTTQGb 3052-3061 
HLNGSNVQVLC 3068-3077 
IYWADAREDYIEFASLDGSNd 3184-3203 
DLHVFHALRQPDVPC 3258-3271 
CIPGIFRCNGQDNCGDGEDE’ 3407-3426 
CIPARWKCDGEDD’ 3488-3500 
CVPGRWQCDYDNDCGDNSDEEe 3529-3549 
FVCPPNRPFRd 3674-3683 
KTHNTCKAEGSEYQVLYb 3836-3852 
QIDRGV’ 3925-3930 
DGTLRETLVODN$ 4013-4024 
YSREKNQPKPh 
aN-terminal sequence of S-[?]carboxymethylated 500 kDa chain. A 
des-Ala sequence was seen in equimolar yield. The Cys-residue was 
assigned from a 25% increase in radioactivity in steps 7 and 8. 
bCNBr fragment from 500 kDa chain, purified by HPLC. 
‘CNBr fragment from 500 kDa chain, purified by SDS-PAGE. 
dTryptic peptide from a pool of large CNBr fragments originating 
from 500 kDa chain. 
‘Tryptic peptide from 500 kDa chain. 
‘N-terminal sequence of 85 kDa chain. 
gLarge CNBr fragment originating from pool containing 85 kDa and 
40 kDa species. 
hN-terminal sequence of 40 kDa species. 
Partial sequences of a random selection of 36 pep- 
tides accounting for 524 residues from the 500 kDa 
chain are shown in Table I. In every case these se- 
quences matched with segments located between 
residues 316 and 3852 in the amino acid sequence of 
proLRP [I] (Fig. 2). The 500 kDa chain of CQMR con- 
tained two N-terminal sequences (8 residues determin- 
ed) in approx. equimolar yield, the first corresponding 
to that predicted for proLRP [l], the second to its des- 
Ala sequence. In addition, the sequence of a 1772 bp 
cDNA hybridizing with a degenerate oligo-deoxy- 
nucleotide probe based on the peptide sequence Gln- 
Cys-Asp-Tyr-Asp-Asn-Asp-Cys (Fig. 2) revealed com- 
plete identity with nucleotides 10289-12060 of proLRP’ 
111. 
No partial peptide sequences matching residues 
downstream of residue 3852 of proLRP were obtained 
from the CQMR 500 kDa chain. However, sequenator 
analysis of the 85 kDa chain revealed a six-residue 
match starting from residue 3925 of proLRP (Table I). 
Furthermore, the N-terminal sequence of an approx. 40 
kDa CNBr fragment obtained from the pool containing 
the 85 kDa and 40 kDa species matched with residues 
4013-4024 of proLRP (Table I). Hence, the results of 
partial sequence analysis of azMR show that its 500 
kDa chain as well as its 85 kDa chain are contained 
within the sequence of proLRP (Fig. 2). The random se- 
quence data obtained from the large chain of CYZMR and 
the presence of approx. 17% carbohydrate [13] are in 
agreement with the size of at least 500 kDa. 
Intracellular processing of proLRP occurs at the 
tetrabasic sequence -Arg-His-Arg-Arg (3921-3924) [2]. 
Since the amino acid composition of the 500 kDa chain 
[13] is in excellent agreement with that calculated for 
residues l-3920 of LRP, we conclude that it most likely 
is identical with the 515 kDa a-subunit of LRP [2]. 
Although the sequence data of the 85 kDa chain of 
CY~MR containing the membrane spanning segment are 
less extensive, this chain is likely to be the P-subunit of 
LRP. The 85 kDa chain contains seven Asn-residues 
which can potentially by glycosylated. The smearing of 
the 85 kDa chain in SDS-PAGE (Fig. 1) indicates a 
heterogeneous pattern of glycosylation. As discussed in 
[12] the species of approx. 70-75 kDa, present in 
variable amounts, possibly results from a slight 
degradation of the 500 kDa chain, but their position 
could not be determined by sequence analysis. Fig. 2 
shows a schematic representation of the domain struc- 
ture of LRP [1,2] and the localization of the stretches of 
partial sequence determined in (r2MR. 
The N-terminal sequence (10 residues determined) of 
the 40 kDa species in the azMR preparation (Table I) 
neither matched with any segment of LRP nor with pro- 
tein sequences contained in the PIR/GenBank 
databases, indicating that it is a protein of distinct 
genetic origin. 
5. DISCUSSION 
In view of the results of sequence analysis, the 3 pro- 
teins in the affinity purified CYZMR complex are called 
wMR a-subunit, a2MR P-subunit, and 40 kDa 
associated protein. These species are tightly associated 
in detergents such as cholamidopropyldiethyl am- 
153 
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1 YWTO &main 
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Fig. 2. Schematic representation of LRP/GQMR. The model is modified from Refs [t,2f and shows the assembly in LRP/olzMR of type A domains 
(also present in the LDL receptor and several complement proteins), type B domains (also present in the LDL receptor and epidermal growth factor 
precursor) and YWTD domains (also present in the LDL receptor). The membrane spanning segment and the site of processing (arrow) are in- 
dicated. The cu-subunit contains residues l-3920, and the &subunit contains residues 3925-4525 of protRP. The C-terminal approx. 100 residues 
of the &subunit are located intracellularly. Stretches of partial amino acid sequence of cr&IR 500 kDa and 85 kDa chains matching stretches of 
LRP are indicated by solid boxes in the upper set of lines, and the part determined from a partial cDNA is indicated by a continuous line. The 
probe site is indicated by a cross, 
~~n~~pr~~~~~ sulfmate or octyl-P-D-glueopyranoside, 
and separation may be achieved by high salt or SDS at 
low concentrations [IO-121. Previous work has shown 
that binding of olzM-proteinase occurs to the a2MR CY- 
subunit ilO-121. Binding occurs with similar affinities 
to immobilized cvzMR complex and to tv2MR in intact 
cells and membranes flO,l f,5,6]. In fact, binding pro- 
files are indistinguishable when experiments are per- 
formed under comparable conditions (divalent binding 
to pairs Of receptors at 4”C, K&s. approx. 40 pM 
(S.K.M. and J.G., unpublished)). Thus, cy2M-pro- 
teinase binds to the a-subunit which is non-covalently 
associated with the extracellular part of the membrane- 
anchored P-subunit. 
The proposal that LRP functions as a receptor for 
lipoproteins was reviewed by Soutar [15] who conclud- 
ed that LRP may have other functions as well, or even 
instead. Uptake of lipid from rabbit /3-VLDL artificial- 
ly enriched with human ~polipoprotei~ E occurred into 
LDL receptor deficient human fibroblasts and was 
blocked by antibodies against proLRP [ 161, The enrich- 
ed @-VLDL showed Ca’ ’ dependent binding to LRP in 
a ligand blotting assay, and the binding was blocked by 
the inclusion of human apolipoprotein C [I9]. 
Apolip~protein E incorporated into liposomes has also 
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been reported to bind to a receptor having the 
characteristics of LRP in Xmman hepatic membranes, 
although in a Ca2+ independent way [IS]. Others have 
found Ca” dependent, but apolipoprotein E inde- 
pendent binding of rabbit LDL to a rat hepatic receptor 
compatible with LRP 1171. Taken together with the 
structural features of LRP, the binding and uptake ex- 
periments, in spite of their apparent mutual incon- 
sistencies, do suggest hat LRP, besides being the func- 
tional receptor for a2Mvproteinase complexes, has as 
yet unsettled functions in lipoprotein metabolism. 
Binding of apoliproteins B and E to the LDL receptor 
depends in part on a determinant containing the con- 
served sequence -Arg-X-X-Arg-Lys-Arg-X-X-Arg/Lys- 
located within residues 3345-3381, and 140-150, 
respectively, of the two proteins [26,27]. The receptor 
recognition site in cr2M and other CYMS is located in the 
C-terminal 138-residue domain (residues 13 14- I45 1) 
128,293. In view of the possibility that azMR may also 
bind and internalize lipoproteins we examined whether 
the sequence shown above is present in the aMs. The 
search proved negative; but, intriguingly, an 8 1 -residue 
segment of apolipoprotein B (residues 3342-3422) 
aligned with residues 1314-1394 of human azM (18% 
identities); likewise a 68residue segment of apoiipopro- 
Volume 276, number 1,2 FEBS LETTERS December 1990 
tein E (residues 95-158) aligned with residues 
1314-1372 of a2M (17% identities). These alignments 
had the highest scores when the sequences of the entire 
proteins were compared, but their significance is 
presently unclear. 
In conclusion we have provided evidence that LRP, 
thought to be a novel recycling lipoprotein receptor, is 
the receptor for cyzM-proteinase complexes. Its possible 
role in lipoprotein metabolism needs to be elucidated. 
The 40 kDa peptide in the azMR complex, not noticed 
in previous work on LRP [1,2], is of distinct genetic 
origin, and its possible role in the function of CQMR for 
clearance of cr2M-proteinase complexes remains to be 
clarified. 
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